Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Qiu

Showing results (441-450 of 474) with videos related to

Pageof 48
Sort By:
Acta Pharmacologica Sinica|March 4, 2025
YY1/HIF-1α/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney diseaseTing-Ting Yang, Yu-Ting Shao, Qian Cheng, et al.
Cell Reports. Medicine|November 17, 2022
Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinomaYang Zhang, Miao-Zhen Qiu, Ju-Feng Wang, et al.
JAMA Oncology|May 5, 2022
Evaluation of Safety of Treatment With Anti-Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors: A Phase 1 Nonrandomized Clinical TrialMiao-Zhen Qiu, Yang Zhang, Ye Guo, et al.
Cell Reports. Medicine|October 8, 2021
Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysisFeng Wang, Ming-Ming He, Yi-Chen Yao, et al.
BMC Cancer|October 1, 2022
Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancerMing-Yu Lai, Shi-Yang Kang, Yu-Ting Sun, et al.
The Oncologist|November 18, 2022
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I TrialsXiao-Li Wei, Yang Zhang, Hong-Yun Zhao, et al.
Cell Death Discovery|December 28, 2018
A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patientsJia-Huan Lu, Zhi-Xiang Zuo, Wei Wang, et al.
Hepatology (Baltimore, Md.)|March 12, 2014
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expressionDong-Liang Chen, Zhi-Qiang Wang, Zhao-Lei Zeng, et al.
JAMA Network Open|December 9, 2022
Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric CancerZe-Xian Liu, Xiao-Long Zhang, Qi Zhao, et al.
Chinese Journal of Cancer|June 27, 2015
Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximabFeng Wang, Long Bai, Tian-Shu Liu, et al.
Pageof 48

Showing results (441-450 of 474) with videos related to

Sort By:
Pageof 48
Acta Pharmacologica Sinica|March 4, 2025
YY1/HIF-1α/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney diseaseTing-Ting Yang, Yu-Ting Shao, Qian Cheng, et al.
Cell Reports. Medicine|November 17, 2022
Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinomaYang Zhang, Miao-Zhen Qiu, Ju-Feng Wang, et al.
JAMA Oncology|May 5, 2022
Evaluation of Safety of Treatment With Anti-Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors: A Phase 1 Nonrandomized Clinical TrialMiao-Zhen Qiu, Yang Zhang, Ye Guo, et al.
Cell Reports. Medicine|October 8, 2021
Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysisFeng Wang, Ming-Ming He, Yi-Chen Yao, et al.
BMC Cancer|October 1, 2022
Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancerMing-Yu Lai, Shi-Yang Kang, Yu-Ting Sun, et al.
The Oncologist|November 18, 2022
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I TrialsXiao-Li Wei, Yang Zhang, Hong-Yun Zhao, et al.
Cell Death Discovery|December 28, 2018
A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patientsJia-Huan Lu, Zhi-Xiang Zuo, Wei Wang, et al.
Hepatology (Baltimore, Md.)|March 12, 2014
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expressionDong-Liang Chen, Zhi-Qiang Wang, Zhao-Lei Zeng, et al.
JAMA Network Open|December 9, 2022
Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric CancerZe-Xian Liu, Xiao-Long Zhang, Qi Zhao, et al.
Chinese Journal of Cancer|June 27, 2015
Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximabFeng Wang, Long Bai, Tian-Shu Liu, et al.
Pageof 48